Search Results - "Lazova, R."

Refine Results
  1. 1

    Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma by Scortegagna, M, Ruller, C, Feng, Y, Lazova, R, Kluger, H, Li, J-L, De, S K, Rickert, R, Pellecchia, M, Bosenberg, M, Ronai, Z A

    Published in Oncogene (21-08-2014)
    “…Phosphoinositide-dependent kinase-1 (PDK1) is a serine/threonine protein kinase that phosphorylates members of the conserved AGC kinase superfamily, including…”
    Get full text
    Journal Article
  2. 2
  3. 3

    HSP90 as a marker of progression in melanoma by McCarthy, M.M., Pick, E., Kluger, Y., Gould-Rothberg, B., Lazova, R., Camp, R.L., Rimm, D.L., Kluger, H.M.

    Published in Annals of oncology (01-03-2008)
    “…HSP90 chaperones molecules critical for cell survival and malignant progression, including mutated B-raf. HSP90-targeting agents are in clinical trials. No…”
    Get full text
    Journal Article
  4. 4

    The role of new molecular tests in the diagnosis of melanoma in a setting of congenital nævus in an infant by Masson Regnault, M, Fraitag, S, Lamant, L, Maza, A, De la Fouchardière, A, Tournier, E, Lauwers, F, Carfagna, L, Meyer, N, De Berail, A, Busam, K J, Lazova, R, Mazereeuw-Hautier, J

    “…Congenital and infantile melanomas are extremely rare. We report a case of a child presenting at birth with a giant congenital nevus complicated by melanoma…”
    Get full text
    Journal Article
  5. 5

    Desmoplastic melanoma: A 12-year experience with sentinel lymph node biopsy by Broer, P.N, Walker, M.E, Goldberg, C, Buonocore, S, Braddock, D.T, Lazova, R, Narayan, D, Ariyan, S

    Published in European journal of surgical oncology (01-07-2013)
    “…Abstract Aims Given the paucity of data regarding nodal involvement in desmoplastic melanoma (DM), we decided to review the incidence of nodal metastasis in…”
    Get full text
    Journal Article
  6. 6
  7. 7

    A Variant in a MicroRNA complementary site in the 3′ UTR of the KIT oncogene increases risk of acral melanoma by Godshalk, S E, Paranjape, T, Nallur, S, Speed, W, Chan, E, Molinaro, A M, Bacchiocchi, A, Hoyt, K, Tworkoski, K, Stern, D F, Sznol, M, Ariyan, S, Lazova, R, Halaban, R, Kidd, K K, Weidhaas, J B, Slack, F J

    Published in Oncogene (31-03-2011)
    “…MicroRNAs (miRNAs) are small ∼22nt single stranded RNAs that negatively regulate protein expression by binding to partially complementary sequences in the 3′…”
    Get full text
    Journal Article
  8. 8

    Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of BrafV600E::Pten–/– melanoma by Scortegagna, M, Ruller, C, Feng, Y, Lazova, R, Kluger, H, Li, J-L, De, S K, Rickert, R, Pellecchia, M, Bosenberg, M, Ronai, Z A

    Published in Oncogene (21-08-2014)
    “…Phosphoinositide-dependent kinase-1 (PDK1) is a serine/threonine protein kinase that phosphorylates members of the conserved AGC kinase superfamily, including…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    The development of lentigines within segmental achromic nevi by Bolognia, Jean L., Lazova, Rossitza, Watsky, Kalman

    “…The classic definition of a nevus depigmentosus is a stable congenital leukoderma that may be localized, segmental, or less often, systematized. Herein we…”
    Get full text
    Journal Article
  14. 14

    Morphea limited to the superficial reticular dermis : An underrecognized histologic phenomenon by MCNIFF, J. M, GLUSAC, E. J, LAZOVA, R. Z, CARROLL, C. B

    Published in The American journal of dermatopathology (01-08-1999)
    “…Morphea (localized scleroderma) is a disease of unknown etiology, presenting as circumscribed areas of indurated skin. Histologically, most cases of morphea…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Under the microscope. Surgeons, pathologists, and melanocytic nevi by Lazova, R, McNiff, J M, Glusac, E J

    Published in Clinics in plastic surgery (01-07-2000)
    “…Predicting the biologic behavior of melanocytic neoplasms (benign versus malignant) based on histology is one of the most difficult challenges in surgical…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf super(V600E)::Pten super(-/-) melanoma by Scortegagna, M, Ruller, C, Feng, Y, Lazova, R, Kluger, H, Li, J-L, De, S K, Rickert, R, Pellecchia, M, Bosenberg, M, Ronai, Z A

    Published in Oncogene (21-08-2014)
    “…Phosphoinositide-dependent kinase-1 (PDK1) is a serine/threonine protein kinase that phosphorylates members of the conserved AGC kinase superfamily, including…”
    Get full text
    Journal Article
  20. 20

    Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of [Braf.sup.V600E]::[Pten.sup.-/-] melanoma by Scortegagna, M, Ruller, C, Feng, Y, Lazova, R, Kluger, H, Li, J.-L, De, S.K, Rickert, R, Pellecchia, M, Bosenberg, M, Ronai, Z.A

    Published in Oncogene (21-08-2014)
    “…Phosphoinositide-dependent kinase-1 (PDK1) is a serine/threonine protein kinase that phosphorylates members of the conserved AGC kinase superfamily, including…”
    Get full text
    Journal Article